Market Cap 155.70M
Revenue (ttm) 0.00
Net Income (ttm) -90.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,209,500
Avg Vol 3,856,570
Day's Range N/A - N/A
Shares Out 217.00M
Stochastic %K 38%
Beta 2.82
Analysts Strong Sell
Price Target $9.33

Company Profile

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacet...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 825 6990
Address:
171 Oyster Point Boulevard, Suite 500, South San Francisco, United States
Spinaroonie
Spinaroonie Jun. 27 at 8:10 PM
$TNYA well what direction does everyone think the stock will go now that the CEO stepped down ??
3 · Reply
Cel55
Cel55 Jun. 27 at 4:24 PM
$TNYA "Friends,while waiting for June 30, I remain on the side that believes in the company’s story and continue increasing my share position through buy-and-sell trades during this process; however, as the expiration date of the June 30 maturity warrants approaches, the sharp contraction of trading volume to historically low levels despite the potential issuance of approximately 37.5 million shares suggests that institutional investors may be managing their delta-neutral arbitrage positions through a silent book-entry transfer process without triggering market volatility. This technical setup brings us to a critical dilemma: starting July 1, will the removal of the mechanical pressure create a rational cleanup operation in the stock, with the 29.3 million short positions being neutralized through short-covering purchases, or will the new shares entering the market after warrant conversion create a supply surplus that turns into a dilution shock, limiting the expected recovery?"
4 · Reply
Minecraftbeers
Minecraftbeers Jun. 27 at 1:19 PM
$TNYA I interviewed a real patient from Tenaya’s clinical trials in Cleveland, Ohio! Here is Part 1: Q: What symptoms were you managing before the trial and how would you describe them now? A: Before, I had Heart murmur, frequent AFIB, Persistent chest pains, excessive sweating. After, there was initial heart surgery to remove excess tissue and treatments of TN-201 [MyPEAK-1]. All of the previous symptoms no longer apply. Overall, absolutely life changing. Only symptoms unique to post-dose, i got extremely sick and had to be hospitalized. they used an immuno-suppressant after dosage similar to post-heart surgery meds. I had to be isolated but still managed to catch a sickness. Recovered as normal and is fine today. & prior to any treatments, my local heart doctor told me i had approx. 10 years left on my heart. After treatments, my doctor said he would guess closer to 40 years left now. I also had no pre-existing heart conditions besides this. No high blood pressure or blockages.
0 · Reply
Yung_Ball3R
Yung_Ball3R Jun. 27 at 5:24 AM
0 · Reply
Minecraftbeers
Minecraftbeers Jun. 27 at 12:58 AM
LETS GO $TNYA!!! JUNE 30TH FOR THE WIN!
1 · Reply
Crazyrussiankid
Crazyrussiankid Jun. 26 at 11:03 PM
$TNYA $2.2/share by end of the year
3 · Reply
Raumerica
Raumerica Jun. 26 at 8:19 PM
$TNYA Really lying scumbag? How about some proof. By now, anybody reading this board knows if you are breathing, you are lying. To all newbies, block this clown! He lies EVERYDAY!
0 · Reply
AutisticRetardo
AutisticRetardo Jun. 26 at 7:21 PM
$TNYA New FINRA short interest data dropped today. 28.6M shares short(76% of the 37.5M series b warrants) with 8.4 days to cover. I think it is safe to say that the price action we've seen on the recent good news was the result of mechanical arbitrage and has no bearing on the scientific merits of this company. Three more trading days until expiration 🤑 - When a short position only grows in lockstep with the birth of new warrants, it's because the institutions buying the warrants are immediately shorting the stock against them to lock in their risk-free spreads. - The fact that the stock has been relentlessly "glued" to the $0.71–$0 .73 range on incredibly low volume right before expiration is a classic sign of market-maker stabilization, not directional aggressive shorting. - If a small-cap biotech stock had nearly 30 million shares of organic short interest, the CTB would usually skyrocket into the triple digits because shares would be incredibly scarce to find.
2 · Reply
Spinaroonie
Spinaroonie Jun. 26 at 6:32 PM
$TNYA 100 percent getting a RS read online that someone knows employees for Tenaya Therapeutics that were present during a meeting with the soon to be fired CEO
0 · Reply
Minecraftbeers
Minecraftbeers Jun. 26 at 5:56 PM
$TNYA’s drugs and programs have shown remarkable results. A lot of patients in the clinical trials have spoken up about how it has positively impacted their lives. It’s only a matter of time before TNYA’s hard work and dedication pays off! I’m long and bullish for TNYA! Holding strong with 6,444 shares! Adding more soon!
2 · Reply
Latest News on TNYA
Tenaya Therapeutics Slides: FY 2026

Jun 4, 2026, 3:10 PM EDT - 24 days ago

Tenaya Therapeutics Slides: FY 2026


Tenaya Therapeutics management to meet with Piper Sandler

2026-06-03T20:45:27.000Z - 25 days ago

Tenaya Therapeutics management to meet with Piper Sandler


Tenaya Therapeutics Transcript: Study result

Jun 3, 2026, 8:00 AM EDT - 25 days ago

Tenaya Therapeutics Transcript: Study result


Tenaya Therapeutics Press release: Study result

Jun 3, 2026, 8:00 AM EDT - 25 days ago

Tenaya Therapeutics Press release: Study result


Tenaya Therapeutics Slides: Study result

Jun 3, 2026, 8:00 AM EDT - 25 days ago

Tenaya Therapeutics Slides: Study result


Tenaya Therapeutics Transcript: Study update

May 15, 2026, 10:30 AM EDT - 6 weeks ago

Tenaya Therapeutics Transcript: Study update


Tenaya Therapeutics Press release: Study update

May 15, 2026, 10:30 AM EDT - 6 weeks ago

Tenaya Therapeutics Press release: Study update


Tenaya Therapeutics Slides: Study update

May 15, 2026, 10:30 AM EDT - 6 weeks ago

Tenaya Therapeutics Slides: Study update


Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c)

2026-05-07T00:34:31.000Z - 7 weeks ago

Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c)


Tenaya Therapeutics Earnings release: Q1 2026

May 6, 2026, 4:00 PM EDT - 7 weeks ago

Tenaya Therapeutics Earnings release: Q1 2026


Tenaya Therapeutics Quarterly report: Q1 2026

May 6, 2026, 4:00 PM EDT - 7 weeks ago

Tenaya Therapeutics Quarterly report: Q1 2026


Tenaya Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Tenaya Therapeutics Proxy statement: Proxy filing


Tenaya Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Tenaya Therapeutics Proxy statement: Proxy filing


Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)

2026-03-11T20:27:09.000Z - 3 months ago

Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)


Tenaya Therapeutics Annual report: Q4 2025

Mar 11, 2026, 4:00 PM EDT - 3 months ago

Tenaya Therapeutics Annual report: Q4 2025


Tenaya Therapeutics Earnings release: Q4 2025

Mar 11, 2026, 4:00 PM EDT - 3 months ago

Tenaya Therapeutics Earnings release: Q4 2025


Tenaya Therapeutics presents preclinical data evaluating TN-301

2026-03-09T12:41:56.000Z - 3 months ago

Tenaya Therapeutics presents preclinical data evaluating TN-301


Tenaya Therapeutics announces 2026 strategic priorities

2026-01-09T13:41:19.000Z - 6 months ago

Tenaya Therapeutics announces 2026 strategic priorities


Tenaya Therapeutics 50M share Spot Secondary priced at $1.20

2025-12-12T07:00:10.000Z - 7 months ago

Tenaya Therapeutics 50M share Spot Secondary priced at $1.20


Tenaya Therapeutics Announces Pricing of Public Offering

Dec 12, 2025, 12:16 AM EST - 7 months ago

Tenaya Therapeutics Announces Pricing of Public Offering


Tenaya Therapeutics Transcript: Study Result

Dec 11, 2025, 5:00 PM EST - 7 months ago

Tenaya Therapeutics Transcript: Study Result


Tenaya Therapeutics Press release: Study Result

Dec 11, 2025, 5:00 PM EST - 7 months ago

Tenaya Therapeutics Press release: Study Result


Tenaya Therapeutics Slides: Study Result

Dec 11, 2025, 5:00 PM EST - 7 months ago

Tenaya Therapeutics Slides: Study Result


Tenaya Therapeutics  files to sell common stock, no amount given

2025-12-11T21:20:52.000Z - 7 months ago

Tenaya Therapeutics files to sell common stock, no amount given


Tenaya Therapeutics Announces Proposed Public Offering

Dec 11, 2025, 4:02 PM EST - 7 months ago

Tenaya Therapeutics Announces Proposed Public Offering


Tenaya Therapeutics Slides: Corporate Presentation

Dec 11, 2025, 7:00 AM EST - 7 months ago

Tenaya Therapeutics Slides: Corporate Presentation


Tenaya Therapeutics Transcript: Status Update

Nov 10, 2025, 8:00 AM EST - 8 months ago

Tenaya Therapeutics Transcript: Status Update


Tenaya Therapeutics Press release: Status Update

Nov 10, 2025, 8:00 AM EST - 8 months ago

Tenaya Therapeutics Press release: Status Update


Tenaya Therapeutics Slides: Status Update

Nov 10, 2025, 8:00 AM EST - 8 months ago

Tenaya Therapeutics Slides: Status Update


Tenaya Therapeutics reports Q3 EPS (12c), consensus (15c)

2025-11-10T12:06:39.000Z - 8 months ago

Tenaya Therapeutics reports Q3 EPS (12c), consensus (15c)


Tenaya Therapeutics Earnings release: Q3 2025

Nov 10, 2025, 7:00 AM EST - 8 months ago

Tenaya Therapeutics Earnings release: Q3 2025


Tenaya Therapeutics Quarterly report: Q3 2025

Nov 10, 2025, 7:00 AM EST - 8 months ago

Tenaya Therapeutics Quarterly report: Q3 2025


Tenaya Therapeutics Slides: Corporate Presentation

Sep 9, 2025, 7:00 AM EDT - 10 months ago

Tenaya Therapeutics Slides: Corporate Presentation


Tenaya Therapeutics Transcript: KOL Event

Aug 26, 2025, 11:30 AM EDT - 10 months ago

Tenaya Therapeutics Transcript: KOL Event


Tenaya Therapeutics Slides: Corporate Presentation

Aug 13, 2025, 4:00 PM EDT - 11 months ago

Tenaya Therapeutics Slides: Corporate Presentation


Tenaya Therapeutics Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 11 months ago

Tenaya Therapeutics Quarterly report: Q2 2025


Tenaya Therapeutics Earnings release: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 11 months ago

Tenaya Therapeutics Earnings release: Q2 2025


Tenaya Therapeutics Earnings release: Q1 2025

May 7, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Earnings release: Q1 2025


Tenaya Therapeutics Quarterly report: Q1 2025

May 7, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Quarterly report: Q1 2025


Tenaya Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Tenaya Therapeutics Proxy statement: Proxy Filing


Tenaya Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Tenaya Therapeutics Proxy statement: Proxy Filing


Tenaya Therapeutics Annual report: Q4 2024

Mar 10, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Annual report: Q4 2024


Tenaya Therapeutics Earnings release: Q4 2024

Mar 10, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Earnings release: Q4 2024


Tenaya Therapeutics Transcript: Study Update

Dec 17, 2024, 8:00 AM EST - 1 year ago

Tenaya Therapeutics Transcript: Study Update


Tenaya Therapeutics Press release: Study Update

Dec 17, 2024, 8:00 AM EST - 1 year ago

Tenaya Therapeutics Press release: Study Update


Tenaya Therapeutics Slides: Study Update

Dec 17, 2024, 8:00 AM EST - 1 year ago

Tenaya Therapeutics Slides: Study Update


Tenaya Therapeutics Quarterly report: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

Tenaya Therapeutics Quarterly report: Q3 2024


Tenaya Therapeutics Earnings release: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

Tenaya Therapeutics Earnings release: Q3 2024


Tenaya Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Quarterly report: Q2 2024


Tenaya Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Earnings release: Q2 2024


Tenaya Therapeutics Announces Research Leadership Updates

Jun 27, 2024, 5:00 PM EDT - 2 years ago

Tenaya Therapeutics Announces Research Leadership Updates


Tenaya Therapeutics Quarterly report: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Quarterly report: Q1 2024


Tenaya Therapeutics Earnings release: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Earnings release: Q1 2024


Tenaya Therapeutics Proxy statement: Proxy Filing

Apr 17, 2024, 8:00 AM EDT - 2 years ago

Tenaya Therapeutics Proxy statement: Proxy Filing


Tenaya Therapeutics Proxy statement: Proxy Filing

Apr 17, 2024, 8:00 AM EDT - 2 years ago

Tenaya Therapeutics Proxy statement: Proxy Filing


Tenaya Therapeutics Earnings release: Q4 2023

Mar 18, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Earnings release: Q4 2023


Tenaya Therapeutics Annual report: Q4 2023

Mar 18, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Annual report: Q4 2023


Tenaya Therapeutics Quarterly report: Q3 2023

Nov 9, 2023, 4:00 PM EST - 2 years ago

Tenaya Therapeutics Quarterly report: Q3 2023


Tenaya Therapeutics Earnings release: Q3 2023

Nov 9, 2023, 4:00 PM EST - 2 years ago

Tenaya Therapeutics Earnings release: Q3 2023


Tenaya Therapeutics Slides: Corporate Presentation

Nov 1, 2023, 8:00 AM EDT - 2 years ago

Tenaya Therapeutics Slides: Corporate Presentation


Spinaroonie
Spinaroonie Jun. 27 at 8:10 PM
$TNYA well what direction does everyone think the stock will go now that the CEO stepped down ??
3 · Reply
Cel55
Cel55 Jun. 27 at 4:24 PM
$TNYA "Friends,while waiting for June 30, I remain on the side that believes in the company’s story and continue increasing my share position through buy-and-sell trades during this process; however, as the expiration date of the June 30 maturity warrants approaches, the sharp contraction of trading volume to historically low levels despite the potential issuance of approximately 37.5 million shares suggests that institutional investors may be managing their delta-neutral arbitrage positions through a silent book-entry transfer process without triggering market volatility. This technical setup brings us to a critical dilemma: starting July 1, will the removal of the mechanical pressure create a rational cleanup operation in the stock, with the 29.3 million short positions being neutralized through short-covering purchases, or will the new shares entering the market after warrant conversion create a supply surplus that turns into a dilution shock, limiting the expected recovery?"
4 · Reply
Minecraftbeers
Minecraftbeers Jun. 27 at 1:19 PM
$TNYA I interviewed a real patient from Tenaya’s clinical trials in Cleveland, Ohio! Here is Part 1: Q: What symptoms were you managing before the trial and how would you describe them now? A: Before, I had Heart murmur, frequent AFIB, Persistent chest pains, excessive sweating. After, there was initial heart surgery to remove excess tissue and treatments of TN-201 [MyPEAK-1]. All of the previous symptoms no longer apply. Overall, absolutely life changing. Only symptoms unique to post-dose, i got extremely sick and had to be hospitalized. they used an immuno-suppressant after dosage similar to post-heart surgery meds. I had to be isolated but still managed to catch a sickness. Recovered as normal and is fine today. & prior to any treatments, my local heart doctor told me i had approx. 10 years left on my heart. After treatments, my doctor said he would guess closer to 40 years left now. I also had no pre-existing heart conditions besides this. No high blood pressure or blockages.
0 · Reply
Yung_Ball3R
Yung_Ball3R Jun. 27 at 5:24 AM
0 · Reply
Minecraftbeers
Minecraftbeers Jun. 27 at 12:58 AM
LETS GO $TNYA!!! JUNE 30TH FOR THE WIN!
1 · Reply
Crazyrussiankid
Crazyrussiankid Jun. 26 at 11:03 PM
$TNYA $2.2/share by end of the year
3 · Reply
Raumerica
Raumerica Jun. 26 at 8:19 PM
$TNYA Really lying scumbag? How about some proof. By now, anybody reading this board knows if you are breathing, you are lying. To all newbies, block this clown! He lies EVERYDAY!
0 · Reply
AutisticRetardo
AutisticRetardo Jun. 26 at 7:21 PM
$TNYA New FINRA short interest data dropped today. 28.6M shares short(76% of the 37.5M series b warrants) with 8.4 days to cover. I think it is safe to say that the price action we've seen on the recent good news was the result of mechanical arbitrage and has no bearing on the scientific merits of this company. Three more trading days until expiration 🤑 - When a short position only grows in lockstep with the birth of new warrants, it's because the institutions buying the warrants are immediately shorting the stock against them to lock in their risk-free spreads. - The fact that the stock has been relentlessly "glued" to the $0.71–$0 .73 range on incredibly low volume right before expiration is a classic sign of market-maker stabilization, not directional aggressive shorting. - If a small-cap biotech stock had nearly 30 million shares of organic short interest, the CTB would usually skyrocket into the triple digits because shares would be incredibly scarce to find.
2 · Reply
Spinaroonie
Spinaroonie Jun. 26 at 6:32 PM
$TNYA 100 percent getting a RS read online that someone knows employees for Tenaya Therapeutics that were present during a meeting with the soon to be fired CEO
0 · Reply
Minecraftbeers
Minecraftbeers Jun. 26 at 5:56 PM
$TNYA’s drugs and programs have shown remarkable results. A lot of patients in the clinical trials have spoken up about how it has positively impacted their lives. It’s only a matter of time before TNYA’s hard work and dedication pays off! I’m long and bullish for TNYA! Holding strong with 6,444 shares! Adding more soon!
2 · Reply
Raumerica
Raumerica Jun. 26 at 5:53 PM
$TNYA TNYA will EASILY get an 180 day extension IF necessary. I doubt it though: I expect some July fireworks and longs will be celebrating!
0 · Reply
DrGonzo69
DrGonzo69 Jun. 26 at 3:32 PM
$TNYA still patient but its been a loooooong hold.
1 · Reply
Ray89c
Ray89c Jun. 26 at 2:45 PM
$TNYA it’s stuck at this price . Time to go up
1 · Reply
alhabib2018
alhabib2018 Jun. 26 at 2:55 AM
$TNYA shouldn't Nasdaq letter compliance
1 · Reply
GhostTrader11
GhostTrader11 Jun. 25 at 11:33 PM
$TNYA TNYA’s neighbor $FPRX was bashed continuously. Got bought out by AMGN. Use the bashing as a good laugh and the shorting for a better entry. Know what you own. Glta
0 · Reply
lilsilli301
lilsilli301 Jun. 25 at 10:01 PM
1 · Reply
GoNiners
GoNiners Jun. 25 at 9:10 PM
$TNYA hoping this close below .70 on 6/30. Then boom, it rockets sky high.
0 · Reply
Paulfrench
Paulfrench Jun. 25 at 8:42 PM
$TNYA What’s interesting about the last two candles is that there is no bearish divergence (contrary to what one might think); the buyers have maintained control, and this could look like a seller trap... in a few days, volume should pick up again and the price ought to skyrocket (barring any surprises 🤣)... on the chart, I’ve highlighted bearish divergences in red and bullish divergences in yellow.
2 · Reply
Raumerica
Raumerica Jun. 25 at 7:51 PM
$TNYA The lying scumbag POS always post BS on any down day… Lies, lies, and more lies!
1 · Reply
Rolfthewild
Rolfthewild Jun. 25 at 5:52 PM
$TNYA See you guys in a week or so. My lips are sealed for a while.
1 · Reply
Spinaroonie
Spinaroonie Jun. 25 at 5:52 PM
$TNYA almost there longs get ready for a RS!!!
0 · Reply
Raumerica
Raumerica Jun. 24 at 11:02 PM
$TNYA Now “Boring Tangerine”on Reddit, aka lying POS scumbag Spinaroonie, is making up a rumor that the CEO is stepping down on Friday. If Spinaroonie is breathing, he is lying. Block him.
3 · Reply